Our research-based intensive lifestyle intervention (ILI) program was designed to work alongside medication to amplify results, restore metabolic balance, and support ongoing health even after medication use has ceased
Asthma Medications Individuals with asthma should avoid inhaled forms of glutathione due to potential interactions with asthma medications
Injectable semaglutide reduces A1c by approximately 1.5 to 2.0 percentage points on average, while oral formulations reduce A1c by approximately 1.0 to 1.5 percentage points
A BMI of 40 or above supports E66.01 without requiring a documented comorbidity
Those prescribed non-GLP-1 diabetes medications (e.g., insulin, metformin)
Additionally, semaglutide slows down the emptying of the stomach, leading to increased feelings of fullness and reduced appetite